Pay in 4 interest-free payments of $30.00 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
Bivalirudin-facilitated binding of MPO to BAEC resulted also in functional changes in terms of increased NO consumption as well as enhanced MPO-mediated redox modifications
Solubility: DMSO : 36
CAS Number: 601-75-2
indicating that a transient asymptomatic parasite recrudescence occurs in all survivors
MD2-IN-1 is an inhibitor of Myeloid differentiation protein 2 (MD2) with a KD of 189 μM for the recombinant human MD2 (rhMD2)
AG-213 Size:Contact [email protected] for quotation Bivalirudin-facilitated binding of MPO toAG 213 is an inhibitor of protein tyrosine kinases (PTKs) and epidermal growth factor (EGF) receptor kinase [1,2]. Protein tyrosine kinases (PTKs) have been involved in regulating cell proliferation, cell differentiation, and signaling processes in the immune system. Dysfunction of protein tyrosine kinases result in inflammatory responses and diseases including cancer, atherosclerosis, and psoriasis . The epidermal growth factor receptor (EGFR) is a
US$ 65.00
US$ 125.00
US$ 50.00
US$ 50.00
US$ 50.00
US$ 50.00
US$ 200.00